Time to GAIN: Are Your FDA Marketing Exclusivities Eligible for Extension?

Some innovative drugs are receiving an additional five years of marketing exclusivity on top of their other exclusivities because they qualify under the Generating Antibiotic Incentives Now (GAIN) title of the Food and Drug Administration Safety and Innovation Act as a qualified infectious diseaOriginal Article